Holen Sie sich die Stockscreener-App
35.63
0.45%
0.16
Handel nachbörslich:
35.39
-0.24
-0.67%
Finanzdaten der Viking Therapeutics Inc-Aktie (VKTX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
67.14%
164.74
|
98.56 | 74.57 | 55.47 | 46.24 |
| Operating Income/Loss |
67.14%
-164.74
|
-98.56 | -74.57 | -55.47 | -46.24 |
| Income/Loss From Continuing Operations Before Tax |
73.66%
-157.66
|
-90.79 | -65.56 | -45.63 | -35.42 |
| Income/Loss From Continuing Operations After Tax |
73.66%
-157.66
|
-90.79 | -65.56 | -45.63 | -35.42 |
|
Net Income/Loss
|
73.66%
-157.66
|
-90.79 | -65.56 | -45.63 | -35.42 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.60%
0.45
|
112.32 | 112.13 | 112.07 | 0.775 |
| Diluted Average Shares |
99.60%
0.45
|
112.32 | 112.13 | 112.07 | 0.775 |
| Basic Earnings Per Share |
71.60%
-1.39
|
-0.81 | -0.58 | -0.41 | -0.32 |
| Diluted Earnings Per Share |
71.60%
-1.39
|
-0.81 | -0.58 | -0.41 | -0.32 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):